The National Institute of Allergy and Infectious Diseases will administer the grants, which were awarded to:
The grants stipulate that the institutions use genomics, proteomics, and bioinformatics, among other biological methods, to develop methods of dealing with agents of potential bioterrorist attacks - such as anthrax and smallpox - and emerging novel diseases, such as SARS. The institutions must also provide facilities and services in the case of a national biodefense emergency.
Proteomics will likely play a large role at the RCEs, as reported in ProteoMonitor last month.